# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-25-073130
Filing Date
2025-08-07
Accepted
2025-08-07 17:01:15
Documents
51
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0252310-8k_relmada.htm iXBRL | 8-K | 32296
2 | PRESS RELEASE DATED AUGUST 7, 2025, REGARDING CORPORATE UPDATE AND SECOND QUARTE | ea025231001ex99-1_relmada.htm | EX-99.1 | 128123
3 | CORPORATE PRESENTATION DATED AUGUST 7, 2025 | ea025231001ex99-2_relmada.htm | EX-99.2 | 52229
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 5237
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 625119
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 736473
7 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 589630
8 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 348803
9 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 230844
10 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 381521
11 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 403280
12 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 534131
13 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 603938
14 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 487779
15 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 783313
16 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 597588
17 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 631940
18 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 250987
19 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 465067
20 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 323310
21 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 326292
22 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 281159
23 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 420109
24 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 464207
25 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 535988
26 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 519364
27 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 387437
28 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 187110
29 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 479195
30 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 611520
31 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 374155
32 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 741483
33 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 513965
34 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 394713
35 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 84025
36 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 313964
37 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 365508
38 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 96730
39 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 70351
40 | GRAPHIC | ex99-2_036.jpg | GRAPHIC | 543660
| Complete submission text file | 0001213900-25-073130.txt |  | 22048136

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
41 | XBRL SCHEMA FILE | rlmd-20250807.xsd | EX-101.SCH | 3011
42 | XBRL LABEL FILE | rlmd-20250807_lab.xml | EX-101.LAB | 34239
43 | XBRL PRESENTATION FILE | rlmd-20250807_pre.xml | EX-101.PRE | 22356
53 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0252310-8k_relmada_htm.xml | XML | 3702

Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 251195163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)